SD-OCT easier for paediatric cases

Article

SD-OCT is easier to use when obtaining measurements in children, compared to time-domain OCT, claims a recent study in the British Journal of Ophthalmology.

SD-OCT is easier to use when obtaining measurements in children, compared to time-domain OCT, claims a recent study in the British Journal of Ophthalmology..

Dr Mays El-Dairi et al., Department of Ophthalmology, Duke Eye Centre, Durham, North Carolina, USA, retrospectively and prospectively identified 83 eyes of 83 children from the paediatric glaucoma clinic. Peripapillary retinal nerve fibre layer (RNFL) and macular thickness and volume (MV) were compared between four groups. This included normal eyes, eyes with physiologic cupping, mild glaucomatous eye and IOP and severe glaucoma.

SD-OCT findings were compared with TD-OCT values in a subset of subjects who underwent same day scans with both devices. Exclusion were children with neurologic disorders, refractive error >±5 D, pseudophakia and prematurity.

SD-OCT measurements of average RNFL thickness and MV varied among normal eyes, physiologically cupped and severe glaucoma. SD-OCT and TD-OCT measurements made on the same day correlated linearly, but SD-OCT measurements presented with a lower RNFL and higher macular thickness than TD-OCT. In eyes with severe glaucoma, 30% of patients demonstrated unreliable TD-OCT measurements, but reliable SD-OCT measurements.

To read the abstract please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.